Vivimed Labs Ltd

NSE: VIVIMEDLAB · BSE: 532660 · Pharmaceuticals & Biotechnology · 14 announcements

Share price: ₹6.59
Market cap: ₹54.64 Cr
Revenue (annual): ₹69.99 Cr
Net profit (annual): ₹-176.5 Cr
P/E (TTM): -0.3×Sector 47.4×
Promoter holding: 7.57%-0.20% QoQ
FII holding: 1.64%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Insolvency Petition 4 Board Meeting Date 4 Other Announcement 2 Results Correction 1 Legal & Regulatory 1 Financial Results 1 Debt & Borrowing 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

6 Apr 2026 15:11 IST BSE

Debt & Borrowing

Vivimed Labs Debt & Borrowing

Vivimed Labs Ltd has informed the exchanges that it is outside the purview of the 'Large Corporate' framework as per SEBI circular criteria. This routine regulatory disclosure confirms the company's classification regarding debt issuance and borrowing obligations for the upcoming period.

Read the filing ↗